Equites Radar

SSII · SS Innovations International In

Medical DevicesIndiaAnalyst view: none

$3.48

-0.76% last session

End-of-day data · updated 2026-07-28

Neutral2 bullish · 2 bearish technical signals
To mean target: +101.1%

Market cap

$1B

Enterprise value

$1B

Trailing P/E

Forward P/E

-66.0

Dividend yield

Beta

0.56

Avg volume

0M

Employees

0K

2D change

5D change

10.92%

10D change

8.79%

30D change

18.56%

60D change

0.51%

MTD change

0.51%

YTD change

-30.28%

Analyst Outlook

Consensus rating
Recommendation mean (1–5)
Covering analysts1
Mean price target$7.00
Low price target$7.00
Upside to mean target+101.1%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)57.1
50-day MA$3.71
200-day MA$5.09
Price vs 50-day MA+5.9%
Price vs 200-day MA-22.8%
MACD histogram0.03
Volume vs 3-month avg1.7×
52w low $3.2952w high $9.98

Analyst sentiment over time — SSII

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-06-03

Latest call per bank · past 12 months

Recent rating actions

DateFirmActionRatingPrice target
2026-06-03LUCID CAPITAL MARKETSInitiatesBuy$0.00 $7.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-28

  • RSI (14): RSI is 57 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 5.9% above the 50-day MA ($3.71).
  • Price vs 200-day MA: Trading 22.8% below the 200-day MA ($5.09).
  • MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • MACD (12,26,9): MACD histogram is positive (+0.03) — short-term momentum is improving.
  • 52-week range: Price sits between the 52-week low ($3.29) and high ($9.98).

SSII Price Chart

Loading chart for SSII

Fundamentals

Revenue (TTM)$0M
EBITDA$0M
Free cash flow$0M
Operating cash flow$0M
Book value / share$0.27
Net debt / EBITDA0.5
WACC8.0%
Revenue growth117.00%
Earnings growth

About SS Innovations International In

SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The company also develops NADI – Automated Coronary Anastomotic Connector, a micro stapling device; SSi Multi-Fire Clip Applier, a cartridge-based clip applicator; SSi Robotic Stapler; SSi Maya is an enabling digital platform that compliments the SSI Mantra system and enhances surgical capabilities; SSi Guru is a virtual tele illustration; SSi XR Cognitive Skill Simulator is an extended reality (XR) software platform developed to train and educate surgeons and surgical assistants; SSi MantraM; SSi Mantra Tele Surgeon Console (TSC); and 5mm surgical instruments; SSi Holographic Anatomy, an augmented reality tool; SSi Chitrasa – Advanced DICOM Viewer, an AI enabled application viewer; and SSi Mixed Reality Headset, a medical-grade device. In addition, it offers instrument tips, including forceps, scissors, electrocautery tools, scalpels, and other surgical tools. Further, the company provides accessory products, such as sterile drapes, 3d stereo endoscopes, cannulas, and seals, as well as tele proctoring and telesurgery products. Additionally, it offers installation, repair, maintenance, 24/7 technical support, and proactive health monitoring services. The company sells its products through direct sales organizations and distributor networks. SS Innovations International, Inc. is headquartered in Gurugram, India.

More in Medical Devices

Screen SSII against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.